IDEXX LABORATORIES INC /DE (IDXX)

Import this data to Google Sheets with:

=jivedata("IDXX","financials")

Full statements spill as a table. For one cell: =jivedata("IDXX","Revenue") or =jivedata("IDXX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

IDEXX LABORATORIES INC /DE

IDXX • CIK 0000874716

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Gross Profit	$2,189,970	$2,378,927	$2,659,579	$2,843,294
Operating Income (Loss)	$1,097,128	$1,128,337	$1,360,031	$1,458,603
InterestExpenseNonoperating	—	$31,205	$38,852	$37,788
Interest and Other Income	$5,629	$12,699	$3,010	$2,370
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$1,061,176	$1,109,831	$1,324,189	$1,424,419
Income Tax Expense (Benefit)	$216,134	$221,964	$264,725	$284,763
Net Income (Loss) Attributable to Parent	$845,042	$887,867	$1,059,464	$1,139,656
Revenue from Contract with Customer, Excluding Assessed Tax	$3,660,953	$3,897,504	$4,303,702	$4,553,223
Cost of Goods and Services Sold	—	$1,518,577	$1,644,123	$1,709,929
Selling and Marketing Expense	$566,066	$588,507	$643,547	$672,744
General and Administrative Expense	$335,825	$442,291	$404,794	$450,482
Research and Development Expense	$190,951	$219,792	$251,207	$261,465
Operating Expenses	—	$1,250,590	$1,299,548	$1,384,691
Weighted Average Number of Shares Outstanding, Basic	83,066,000	82,467,000	80,427,000	78,862,000
Weighted Average Number of Shares Outstanding, Diluted	83,978,000	83,246,000	81,025,000	79,302,000
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	912,000	779,000	598,000	440,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$453,932	$288,266	$180,070	$196,933
Accounts Receivable, after Allowance for Credit Loss, Current	$457,445	$473,575	$552,378	$627,083
Inventory, Net	$380,282	$381,877	$377,756	$391,579
Assets	$3,259,925	$3,293,443	$3,350,759	$3,442,335
Other Assets, Current	$203,595	$256,179	$303,623	$293,894
Assets, Current	$1,495,254	$1,399,897	$1,413,827	$1,509,489
Property, Plant and Equipment, Net	$702,177	$713,123	$747,380	$733,238
Operating Lease, Right-of-Use Asset	$115,499	$116,129	$123,228	$122,764
Goodwill	$365,961	$405,100	$414,004	$410,946
Liabilities	$1,775,395	$1,698,130	$1,745,376	$1,829,760
Intangible Assets, Net (Excluding Goodwill)	$84,500	$111,676	$109,843	$98,169
Other Assets, Noncurrent	$496,534	$547,518	$542,477	$567,729
Assets, Noncurrent	$1,764,671	$1,893,546	$1,936,932	$1,932,846
Accounts Payable, Current	$110,643	$114,211	$110,408	$129,097
Accrued Liabilities, Current	$478,712	$502,119	$530,147	$453,169
Line of Credit, Current	$250,000	$250,000	$398,000	$519,000
Long-term Debt, Current Maturities	$74,997	$167,787	$74,995	$149,999
Contract with Customer, Liability, Current	$37,195	$33,799	$35,264	$36,400
Liabilities, Current	$951,547	$1,067,916	$1,148,814	$1,287,665
Deferred Income Tax Liabilities, Net	$7,235	$11,312	$31,865	$52,638
Long-term Debt, Excluding Current Maturities	$622,883	$449,786	$374,842	$299,865
Contract with Customer, Liability, Noncurrent	$28,533	$26,939	$32,177	$32,586
Operating Lease, Liability, Noncurrent	$99,671	$97,836	$101,151	$100,502
Other Liabilities, Noncurrent	$65,526	$44,341	$56,527	$56,504
Liabilities, Noncurrent	$823,848	$630,214	$596,562	$542,095
Common Stock, Value, Issued	$10,751	$10,784	$10,837	$10,872
Additional Paid in Capital, Common Stock	$1,569,565	$1,673,863	$1,826,750	$1,910,290
Common Stock, Other Value, Outstanding	$5,530	$5,885	$6,094	$5,938
Retained Earnings (Accumulated Deficit)	$4,444,571	$5,332,438	$6,391,902	$7,008,760
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-71,206	$-93,645	$-68,844	$-63,538
Treasury Stock, Common, Value	$4,474,681	$5,334,012	$6,561,356	$7,259,747
Stockholders' Equity Attributable to Parent	$1,484,530	$1,595,313	$1,605,383	$1,612,575
Accounts Receivable, Allowance for Credit Loss, Current	$9,501	$12,585	$11,304	$11,304
Common Stock, Shares Authorized	120,000,000	120,000,000	120,000,000	120,000,000
Common Stock, Shares, Issued	107,506,000	107,836,000	108,369,000	108,717,000
Common Stock, Shares, Outstanding	83,032,000	81,604,000	79,712,000	78,874,000
Common Stock, Other Shares, Outstanding	59,000	60,000	59,000	26,000
Treasury Stock, Common, Shares	24,474,000	26,232,000	28,657,000	29,843,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$845,042	$887,867	$1,059,464	$1,139,656
Net Cash Provided by (Used in) Operating Activities	$906,510	$929,001	$1,181,805	$1,371,510
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$2,126	$-9,532	$11,202	$-1,499
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$341,386	$-165,666	$-108,196	$32,339
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$453,932	$288,266	$180,070	$216,628
Depreciation, Depletion and Amortization	$114,908	$129,936	$145,183	$154,082
Payments to Acquire Property, Plant, and Equipment	$133,631	$120,922	$124,676	$117,178
Provision for Loan, Lease, and Other Losses	$5,552	$6,867	$8,429	$10,343
Payments to Acquire Intangible Assets	$0	$10,000	$13,550	$17,242
Deferred Income Taxes and Tax Credits	$-48,306	$-24,194	$131,204	$145,205
PaymentsToAcquireEquitySecuritiesFvNi	$0	$1,004	$756	$1,555
Share-based Payment Arrangement, Noncash Expense	$59,739	$60,295	$60,013	$62,972
Payments to Acquire Businesses, Net of Cash Acquired	$0	$76,694	$0	$0
Other Operating Activities, Cash Flow Statement	$520	$1,218	$5,026	$3,911
Proceeds from Hedge, Investing Activities	$8,377	$1,558	$2,743	$3,934
Net Cash Provided by (Used in) Investing Activities	$-125,254	$-207,062	$-136,239	$-132,041
Increase (Decrease) in Accounts Receivable	$53,871	$28,280	$68,722	$76,677
Proceeds from (Repayments of) Lines of Credit	$-329,000	$0	$148,000	$-60,000
Increase (Decrease) in Inventories	$28,651	$28,001	$789	$-1,505
Repayments of Senior Debt	$75,000	$75,000	$178,385	$74,999
Increase (Decrease) in Accounts Payable	—	$8,086	$-8,573	$8,021
Proceeds from Issuance of Secured Debt	—	—	$250,000	$250,000
Increase (Decrease) in Contract with Customer, Liability	$-3,032	$-4,378	$6,929	$6,929
Increase (Decrease) in Other Operating Assets and Liabilities, Net	$-13,682	$80,665	$156,359	$82,991
Payments of Debt Issuance Costs	$0	$0	$3,738	$3,738
Payments for Repurchase of Common Stock	$71,920	$837,034	$1,216,964	$1,175,809
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	$47,034	$44,492	$93,362	$119,913
Payment for Contingent Consideration Liability, Financing Activities	$3,135	$0	$0	$0
Payment, Tax Withholding, Share-based Payment Arrangement	$9,975	$10,531	$7,239	$10,998
Net Cash Provided by (Used in) Financing Activities	$-441,996	$-878,073	$-1,164,964	$-1,205,631

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("IDXX","financials")

Full statements spill as a table. For one cell: =jivedata("IDXX","Revenue") or =jivedata("IDXX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.